A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2011
10/12/2011	CN102212109A Bone polypeptide compound separated from ossotide injection and application thereof
10/12/2011	CN102212074A Cefonicid sodium hydrate and preparation method and application thereof
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210852A Treatment of T-cell mediated diseases
10/12/2011	CN102210845A Traditional Chinese medicine for treating osseous joint pains
10/12/2011	CN102210822A Traditional Chinese medicine for treating rickets
10/12/2011	CN102210797A Chinese medicinal composition for treating osteoproliferation
10/12/2011	CN102210788A Health-care wine
10/12/2011	CN102210787A Application of philippine violet herb total phenol extract to treatment of hyperuricemia
10/12/2011	CN102210778A Medicine for treating scapulohumeral periarthritis and preparation method thereof
10/12/2011	CN102210774A Medicine for treating rheumatism
10/12/2011	CN102210758A Application of Chinese medicine composition in preparation of medicine for treating ankylosing spondylitis
10/12/2011	CN102210735A Traditional Chinese medicine (TCM) composition for treating fractures and bone injuries
10/12/2011	CN102210734A Atractylis oil dripping pill and preparation method thereof
10/12/2011	CN102210731A Soft capsule containing notoginseng adventitious root extract
10/12/2011	CN102210730A Medicinal composition containing pseudo-ginseng adventitious root extract
10/12/2011	CN102210708A Chinese medicine and egg external application therapy
10/12/2011	CN102210697A Medicine composition for treating metabolic bone diseases
10/12/2011	CN102210696A Pharmaceutical composition containing zoledronic acid
10/12/2011	CN102210691A Use of crataegolic acid and derivatives thereof in preparation of therapeutic and/or preventive medicines for inhibiting osteoclast differentiation and function
10/12/2011	CN102210680A Sinomenine derivatives for treating inflammatory disease by blocking macrophage p38 MAPK (mitogen activated protein kinase) signal transduction pathway
10/12/2011	CN102210672A Application of polyketide in preparation of angiogenesis inhibiting medicine
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN102210535A Neck soothing healing device
10/12/2011	CN101954047B Medicine for treating prolapse of lumbar intervertebral disc
10/12/2011	CN101850093B Medicinal composition for treating hyperplasia of mammary glands
10/12/2011	CN101695558B Traditional Chinese medicinal composition for treating traumatic injury and rheumatism paralysis and preparation method thereof
10/12/2011	CN101690727B Medicament for treating arthritis and preparation method thereof
10/12/2011	CN101669991B Gendarussa wine and manufacturing method and application thereof
10/12/2011	CN101618129B Chinese medical preparation for treating rheumatoid osteopathia
10/12/2011	CN101575582B Lactobacillus separation strains with anti-inflammatory activity and application thereof
10/11/2011	US8034955 triterpenoids such as 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid, used for inhibiting gamma -inteferon-induced nitric oxide production in macrophages; preventing cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/11/2011	CA2393410C Phosphonate compounds
10/06/2011	WO2011123858A2 Ccn3 peptides and analogs thereof for therapeutic use
10/06/2011	WO2011122926A1 A drug delivery system in bone tissue
10/06/2011	WO2011122872A2 Composition comprising coumestrol or a bean extract containing coumestrol
10/06/2011	WO2011122601A1 Intervertebral disc nucleus pulposus stem/progenitor cell, method for culturing same, and application
10/06/2011	WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011	WO2011062765A3 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/06/2011	WO2011050357A3 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245335 New inhibitors for treating diseases associated with an excess transport of hyaluronan
10/06/2011	US20110245276 Photostabilized pharmaceutical compositions
10/06/2011	US20110245269 Inhibitors of Advanced Glycation End Products
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245233 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245208 Compositions and methods for the treatment of somatosensory disorders
10/06/2011	US20110245205 Aminopyrimidines as syk inhibitors
10/06/2011	US20110245204 Cycloalkane-containing sphingosine 1-phosphate agonists
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245187 Mesenchymal cell proliferation promoter and skeletal system biomaterial
10/06/2011	US20110245170 Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
10/06/2011	US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244019 Absorbent fabric implant
10/06/2011	US20110243964 Treatment of orthopedic conditions
10/06/2011	US20110243963 Antibodies to lrp6
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243953 Neutralizing antibodies against gdf-8 and uses therefor
10/06/2011	US20110243945 Anti-Inflammatory Agents
10/06/2011	US20110243944 Fusion Protein Inhibiting Osteoclast Formation, Preparation Method and Medicine Compositions Thereof
10/06/2011	US20110243938 Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243913 Biomaterial Compositions and Methods of Use
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243889 Opioid and opioid-like compounds and uses thereof
10/06/2011	US20110243883 Polymeric biolubricants for medical use
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2794594A1 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371420A1 Veterinary pharmaceutical compositions for the treatment of pain and inflammation
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2370089A1 Compounds and methods for the treatment of autoimmune and inflammatory disease
10/05/2011	EP2369945A2 Companion animal compositions including lipoic acid and methods of use thereof
10/05/2011	EP1948245B1 Compositions and their uses for gene therapy of bone conditions
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use

1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 820